Migraine Nervous System Diseases Migraine
Conditions
Interventions
This longitudinal study consists of three visits: a screening visit (T-12), a baseline visit after 12 weeks (T0) and a follow-up visit (T12).
At T-12, the eligible people sign the inf
Sponsors
Campus Bio Medico University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Diagnosis of migraine with aura or migraine without aura
Exclusion criteria
Exclusion criteria: 1. BMI > 30 2. Cancer 3. Inflammatory bowel disease 4. Celiac disease 5. Type 1 diabetes 6. Chronic renal insufficiency 7. Other neurological disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Monthly migraine days measured using patient self-report 2. Monthly drug intake measured using patient self-report 3. Migraine disability assessment score (MIDAS) measured at 12 weeks before the intervention, baseline, and 12 weeks after the start of the intervention | — |
Countries
Italy
Outcome results
None listed